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Abstract
Control mechanisms of cellular metabolism and energetics in skeletal muscle that may become evident in response to
physiological stresses such as reduction in blood flow and oxygen supply to mitochondria can be quantitatively understood
using a multi-scale computational model. The analysis of dynamic responses from such a model can provide insights into
mechanisms of metabolic regulation that may not be evident from experimental studies. For the purpose, a physiologically-
based, multi-scale computational model of skeletal muscle cellular metabolism and energetics was developed to describe
dynamic responses of key chemical species and reaction fluxes to muscle ischemia. The model, which incorporates key
transport and metabolic processes and subcellular compartmentalization, is based on dynamic mass balances of 30
chemical species in both capillary blood and tissue cells (cytosol and mitochondria) domains. The reaction fluxes in cytosol
and mitochondria are expressed in terms of a general phenomenological Michaelis-Menten equation involving the
compartmentalized energy controller ratios ATP/ADP and NADH/NAD
+. The unknown transport and reaction parameters in
the model are estimated simultaneously by minimizing the differences between available in vivo experimental data on
muscle ischemia and corresponding model outputs in coupled with the resting linear flux balance constraints using a
robust, nonlinear, constrained-based, reduced gradient optimization algorithm. With the optimal parameter values, the
model is able to simulate dynamic responses to reduced blood flow and oxygen supply to mitochondria associated with
muscle ischemia of several key metabolite concentrations and metabolic fluxes in the subcellular cytosolic and
mitochondrial compartments, some that can be measured and others that can not be measured with the current
experimental techniques. The model can be applied to test complex hypotheses involving dynamic regulation of cellular
metabolism and energetics in skeletal muscle during physiological stresses such as ischemia, hypoxia, and exercise.
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Introduction
Skeletal muscle plays a major role in the regulation of whole-
body substrates and energy metabolism, especially under changing
physiological conditions such as ischemia (reduced blood flow),
hypoxia (reduced oxygen supply), and exercise (increased energy
demand). Current experimental techniques provide relatively little
in vivo data on dynamic responses of muscle metabolite
concentrations and metabolic fluxes to such physiological stimuli,
especially in subcellular domains, such as mitochondria. To
quantitatively analyze available in vivo experimental data and
predict nonmeasurable dynamic responses, we developed a
physiologically-based, multi-scale computational model of skeletal
muscle cellular metabolism and energetics. The model is
developed here from our previous model of cellular metabolism
and energetics in skeletal muscle [1] and incorporates inter-
domain transport processes and compartmentalized metabolic
reactions of many key chemical species in both cytosol and
mitochondria.
Developing a mechanistic computational model of substrates
and energy metabolism in complex, multi-scale metabolic systems,
such as skeletal muscle, using a detailed, bottom-up systems
PLoS ONE | www.plosone.org 1 September 2008 | Volume 3 | Issue 9 | e3168approach with sparse in vivo experimental data—with an objective
of achieving a quantitative understanding of the system to
physiological perturbations—is a challenging task. Such a
modeling approach requires information about the general
structural features and catalytic mechanisms of the associated
transporters and enzymes, subcellular metabolic pathways and
fluxes and their control mechanisms, and tissue/organ specific
metabolic characteristics. Such a modeling approach also requires
mechanistic models for key functional components of the system
(e.g., inter-domain transport processes, glycolysis, TCA cycle,
oxidative phosphorylation, fatty acid b-oxidation) to be first
individually developed and validated and then integrated to
emulate the systems behavior at the molecular, subcellular,
cellular, and tissue/organ levels. To avoid this complex approach
and facilitate analysis of available sparse in vivo experimental data
to understand dynamic responses of the system to physiological
stresses, approximations are often made to obtain a simplified
model of the system that includes key functional components
regulating cellular metabolic processes at the desired level of
complexity.
A top-down systems approach is an alternative approach which
has been previously applied to determine and integrate a
representative set of lumped biochemical reactions in vivo
metabolic systems that incorporate primary substrates and key
intermediate metabolites with coupled metabolic energy control-
lers ATP-ADP and NADH-NAD
+ [1–8]. This approach is similar
to the top-down systems approach in metabolic control analysis
proposed by Brand and co-workers [9,10] and is intended to
provide an essential or minimal set of stoichiometrically balanced
lumped biochemical reactions participating in ATP synthesis
within mitochondria from the metabolism of nutrients (e.g.,
glucose, fatty acids, amino acids). Even with such simplifications, a
large number of phenomenological kinetic parameters are
introduced in the governing model equations, which must be
estimated from available sparse in vivo experimental data. To
estimate these unknown parameters, constraint-based, robust
nonlinear optimization methods are needed, as established in
our previous work [1].
To date, no physiologically-based, whole-organ level model of
skeletal muscle cellular metabolism and energetics has been
developed that can be applied to analyze available in vivo
experimental data and predict dynamic metabolic responses to
physiological stimuli in subcellular compartments, such as
mitochondria. Previous models have incorporated some aspects
of glycolysis, TCA cycle, oxidative phosphorylation, and fatty acid
b-oxidation [3–5,11–21]. None of them, however, include
sufficient key substrates/metabolites and/or integrate metabolic
pathways/reactions that are essential in the regulation of cellular
metabolic processes in skeletal muscle in vivo at whole-organ level.
While our recently developed models of skeletal muscle cellular
metabolism and energetics [1] have incorporated key metabolic
pathways and reactions, the intracellular cytosolic and mitochon-
drial compartments were not distinguished. The energy controller
pairs ATP-ADP and NADH-NAD
+ that modulate several key
metabolic reactions in the cytosol and mitochondria have different
concentrations in these two subcellular domains [6–8]. As a
consequence, the model may not accurately predict the dynamics
of several metabolite concentrations and metabolic fluxes that are
critical in the regulation of fuel (carbohydrate, fat, and lactate)
metabolism and cellular respiration during physiological stresses
such as ischemia, hypoxia, and exercise.
In this paper, a physiologically-based, whole-organ level model
of skeletal muscle cellular metabolism and energetics is developed
and applied to study dynamic cellular metabolic responses to
reduced blood flow and oxygen supply to mitochondria (muscle
ischemia). The model, which is extended from our previous model
[1], is based on a multi-scale, top-down systems approach [1–8],
accounts for subcellular compartmentalization, and includes
primary substrates (carbohydrates and fats) and key intermediate
metabolites and metabolic reactions specific to skeletal muscle
metabolic system. The model equations are based on dynamic
mass balances of chemical species in capillary blood and tissue cells
(cytosol and mitochondria) domains. The model also distinguishes
the free and bound forms of O2 and CO2 transport in the blood
and cells. The inter-domain species transport processes are
considered either by passive diffusion or by carrier-mediated
(facilitated) transport. The metabolic reaction fluxes in the
cytosolic and mitochondrial domains are represented by a general
phenomenological Michaelis-Menten equation involving the
compartmentalized ATP/ADP and NADH/NAD
+ energy con-
troller ratios. The phenomenological kinetic parameters of the
model are estimated by using our recently developed constraint-
based, robust nonlinear optimization approach [1]. In this
estimation process, we fit the model output to sparse in vivo
dynamic data on glycolytic and energetic metabolite concentra-
tions from experiments in humans with muscle ischemia previously
published [22]. With the estimated optimal parameter values, the
model is able to simulate dynamic responses of key chemical
species and reaction fluxes to reduced blood flow and oxygen
supply to mitochondria associated with the muscle ischemia.
Materials and Methods
Model Development
The first step in our development of a multi-scale, top-down
computational model of cellular metabolism and energetics in
skeletal muscle was to identify the key intermediate metabolites
and regulatory enzymes in the cellular metabolic pathways of
skeletal muscle. We then integrated available information on
cellular metabolic pathways and fluxes, cellular metabolic control
mechanisms, catalytic enzyme kinetic mechanisms, subcellular
compartmentation and metabolites volumes of distributions, inter-
domain transport mechanisms, and skeletal muscle tissue-specific
metabolic characteristics. A simplified map of the compartmen-
talized cellular metabolic pathways in skeletal muscle is shown in
Figure 1. The lumped biochemical reactions in the metabolic
pathways are generated by stoichiometrically coupling several
sequential elementary reactions. These reactions include the
compartmentalized metabolic energy controller pairs ATP-ADP
and NADH-NAD
+ whose ratios are known to modulate (fine tune)
the reaction fluxes [2,23] in the subcellular compartments. Many
of these lumped reactions are considered irreversible for which the
resting Gibbs free energy (DG) is high and negative in favor of
product formation [24]. As a part of a general formalism for
modeling in vivo metabolic systems (nonequilibrium open systems),
the reversible reactions like lactate dehydrogenase (LDH), creatine
kinase (CK), and adenylate kinase (AK) were decomposed into two
separate irreversible reactions with distinct kinetics [1].
Dynamic mass balance equations
The dynamic mass balance equations are based on a multi-
domain model structure for skeletal muscle consisting of a
spatially-lumped capillary blood domain which exchanges nutri-
ents and metabolic waste products with a spatially-lumped domain
of tissue cells (Figure 2). Although these two domains are separated
by the interstitial fluid (ISF) space, we assume phase-equilibrium of
chemical species between the blood and ISF domains, and
consider them together as the ‘‘blood’’ domain. Furthermore, the
Muscle Metabolic Dynamics
PLoS ONE | www.plosone.org 2 September 2008 | Volume 3 | Issue 9 | e3168Figure 1. Schematic diagram of biochemical pathways depicting various chemical reactions and species involved in the cellular
metabolism of skeletal muscle. The pathways involve 26 lumped reactions among 30 species out of which 8 species (GLC, LAC, PYR, ALA, FFA,
GLR, CO2 and O2) undergo blood-tissue cells exchange. The exchange arrows show the direction of net tissue cells uptake-release rates at normal,
resting conditions. The lumped reactions are further compartmentalized into the cytosolic and mitochondrial reactions. These two subcellular
domains are assumed to be in rapid equilibrium state (the barrier is shown schematically by double dotted lines), so that the species that are
common to both these domains can have the similar dynamics, i.e., Cmit,j(t)=sj.Ccyt,j(t), where sj is the partition coefficient of the species j between
cytosol and mitochondria. In this case, the net transport flux of a species j across the cytosol-mitochondria barrier can quickly become negligible at
the onset of a physiological perturbation (the transport fluxes are shown by double dotted arrows); 10 species (PYR, FAC, CoA, NADH, NAD
+, ATP,
ADP, PI, CO2 and O2) exist in both the cytosolic and mitochondrial domains. GLC: glucose, GLY: glycogen, G6P: glucose-6-phosphate, GA3P:
glyceraldehyde-3-phosphate, 13BPG: 1,3-biphosphate-glycerate, PYR: pyruvate, LAC: lactate, ALA: alanine, TGL: triglycerides, GLR: glycerol, FFA: free
fatty acid, FAC: fatty acyl-CoA, ACoA: acetyl-CoA, CIT: citrate, AKG: a-ketogluterate, SCoA: succinyl-CoA, SUC: succinate, MAL: malate, OXA:
oxaloacetate, CoA: coenzyme-A (free), PCR: phosphocreatine, CR: creatine, PI: inorganic phosphate, CO2: carbon dioxide, O2: oxygen, NADH: reduced
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mitochondrial domains. The chemical species are assumed to be
distributed in these two subcellular domains as per their mass
fractions and volumes of distributions (Table 1). Here, the mass
fraction of a species in a particular domain is defined as the
fractional amount of the species in that domain in comparison to
the total amount of the species in the whole muscle tissue cells.
The volume of distribution of a species in a particular domain is
defined as the anatomical volume of the domain plus the binding
space of the domain for the species. In addition, the species that
are common to both of these domains are assumed to have the
similar dynamics in these two domains, because the species
transport processes between these two domains can be sufficiently
fast [5]. Consequently, a change in the species concentration in
one domain will be proportional to the change in the species
concentration in the other domain: Cmit,j(t)=sj.Ccyt,j(t), where sj is
the equilibrium concentration ratio (or partition coefficient) of
species j between mitochondria and cytosol. In the present model,
a total of 10 chemical species (pyruvate, fatty acyl-CoA, CoA,
ATP, ADP, inorganic phosphate, NADH, NAD
+,O 2, and CO2)
are considered to exist in both the cytosolic and mitochondrial
compartments with negligible transport flux between the com-
partments.
The dynamic mass balance of a chemical species j in the
spatially-lumped blood domain has the following general form:
Vbl,jzVisf,j
  
dCbl,j
 
dt~QC art,j{Cbl,j
  
{Jbl<cyt,j ð1Þ
where Cart,j is the arterial species concentration; Cbl,j is the capillary
blood species concentration (equal to the venous species
concentration Cven,j); Vbl,j and Visf,j are the volumes of distribution
of species j in blood and ISF, and Q is the regional blood flow;
Jbl«cyt,j is the net transport flux (mass per unit time) across the
blood-cytosol exchange barrier (consisting of capillary membrane,
ISF, and tissue cell membrane).
The dynamic mass balance of the chemical species j in the
spatially-lumped tissue cells domain (cytosol and/or mitochondria)
has the following general forms:
Vcyt,jdCcyt,j
 
dt~Jbl<cyt,jzPcyt,j{Ucyt,j; if j[cyt
and j6[mit
ð2aÞ
Vmit,jdCmit,j
 
dt~Pmit,j{Umit,j; if j6[cyt and j[mit ð2bÞ
Vcyt,jzsjVmit,j
  
dCcyt,j
 
dt~Jbl<cyt,jzPcyt,j{Ucyt,j
zPmit,j{Umit,j;
dCmit,j
 
dt~sjdCcyt,j
 
dt; if j[cyt and j[mit
ð2cÞ
where
Px,j~
X
p
bx,j,pwx,p and Ux,j~
X
u
bx,j,uwx,u;
x~ cyt,mit ðÞ
ð2dÞ
Here Cx,j is the species concentration in domain x (cytosol/
mitochondria); Vx,j is the volume of distribution of species j in
domain x; Px,j and Ux,j are the production and utilization of species
Figure 2. Schematic diagram of the structure of the model for blood-tissue cells exchange and cellular metabolism in skeletal
muscle. The compartments are assumed to be perfectly mixed, and the capillary blood and tissue ISF regions are assumed to be in phase-
equilibrium with each other, so that Cisf,j=Cbl,j=Cven,j for any chemical species j. The tissue cells domain is further compartmentalized into the
cytosolic and mitochondrial domains with the chemical species having the similar dynamics in these two subcellular domains, so that
Cmit,j(t)=sjCcyt,j(t), where sj is the partition coefficient of the species j between cytosol and mitochondria. The model accounts for 30 chemical species
in the tissue cells. A total of 8 species (GLC, LAC, PYR, ALA, FFA, GLR, CO2 and O2) undergo blood-tissue cells exchange; 10 species (PYR, FAC, CoA,
NADH, NAD
+, ATP, ADP, PI, CO2 and O2) exist in both the cytosolic and mitochondrial domains with a negligible transport flux (Jcyt«mit,j<0). For
details, see the caption of Figure 1.
doi:10.1371/journal.pone.0003168.g002
nicotinamide adenine dinucleotide, NAD
+: oxidized nicotinamide adenine dinucleotide, ATP: adenosine triphosphate, ADP: adenosine diphosphate,
AMP: adenosine monophosphate.
doi:10.1371/journal.pone.0003168.g001
Muscle Metabolic Dynamics
PLoS ONE | www.plosone.org 4 September 2008 | Volume 3 | Issue 9 | e3168j in domain x; wx,p and wx,u are the reaction fluxes of the reactions
processes that produce and utilize species j in domain x; bx,j,p and
bx,j,u are the corresponding stoichiometric coefficients. For
chemical species which are in the tissue cells (cytosol and/or
mitochondria) but not in the capillary blood, the transport flux
Jbl«cyt,j is zero.
The dynamic mass balance equations for all the chemical
species in blood, cytosol and mitochondrial domains can be
rewritten from our previous model of skeletal muscle metabolism
[1] by accounting for the species compartmentalized volumes of
distributions as laid out in Eqs. (1) and (2a–2c). The dynamic mass
balance equations for O2 and CO2 in these domains are developed
by considering their distinct transport and binding mechanisms
[25,26]. The detailed mass balance equations of the chemical
species, including O2 and CO2, are provided in Materials S1.
Transport and reaction flux equations
The reversible transport flux Jbl«cyt,j (mass per unit time) of the
species j across the blood-cytosol exchange barrier is related to the
concentrations Cbl,j and Ccyt,j by
Table 1. Average species concentrations in the muscle tissue cells [1] and their compartmentalization (distribution) into cytosol
and mitochondria at normal, resting steady-state conditions.*
Species Tissue Cells (100%) Cytosol (90%) Mitochondria (10%)
Concentration (mmol/kg
cell ww) References Mass
# (%)
Concentration (mmol/kg
cyto ww) Mass
# (%)
Concentration (mmol/kg
mito ww)
GLC 0.5 [22,33,38,39,46–50] 100 0.5556 0 0
GLY 95.0 [33,38,46,47,49,51–53] 100 105.56 0 0
G6P 0.25 [22,33,46–50] 100 0.2778 0 0
GA3P 0.08 [33,46,48] 100 0.08889 0 0
13BPG 0.08 [33,46,48] 100 0.08889 0 0
PYR 0.05 [22,38,39,46–48,50] 95 0.0528 5 0.025
LAC 0.78 [22,33,38,39,46,48,50] 100 0.8667 0 0
ALA 1.3 [38,53–55] 100 1.4444 0 0
TGL 15.0 [48,51,52] 100 16.667 0 0
GLR 0.065 [33,47,49,52,56] 100 0.07222 0 0
FFA 0.45 [33,47,49,52,56] 100 0.50 0 0
FAC 0.0035 [49,57] 95 0.003694 5 0.00175
ACoA 0.002 [33,47,55] 0 0 100 0.02
CIT 0.095 [38,39,48,53] 0 0 100 0.95
AKG 0.0125 [38,39] 0 0 100 0.125
SCoA 0.125 [38,39,48,53] 0 0 100 1.25
SUC 0.095 [38,39,48,53] 0 0 100 0.95
MAL 0.095 [38,39,48,53] 0 0 100 0.95
OXA 0.003 [38,39,48,53] 0 0 100 0.03
CoA 0.02 [33,47,55] 80 0.01778 20 0.04
CO2 (F) 1.40 (46 mmHg) [26] 90 1.40 (46 mmHg) 10 1.40 (46 mmHg)
CO2 (T) 15.427 [26] 90 15.427 10 15.427
O2 (F) 0.0338 (25 mmHg) [26] 90 0.0338 (25 mmHg) 10 0.0338 (25 mmHg)
O2 (T) 0.49 [26] 90 0.49 10 0.49
PCR 21.0 [33,38,42,46,48,50,53,58] 100 23.333 0 0
CR 10.5 [33,38,42,46,48,50,53,58] 100 11.667 0 0
PI 2.75 [42,46,48] 90 2.75 10 2.75
NADH 0.05 [46,48,50,53] 0.5 0.2778E-3 99.5 0.4975
NAD
+ 0.45 [46,48,50,53] 30 0.15 70 3.15
ATP (T) 6.2 [22,33,46–48,50,53,58] 86 5.924 14 8.68
ADP (T) 0.8 [22,46,48,50,53,58] 2 0.01778 98 7.84
AMP (T) 0.04 [22,46,48,50,53,58] 100 0.04444 0 0
*The species concentrations (mM or mmol/kg tissue cells ww) are converted from the experimental data (mmol/kg tissue cells dw) in the literature by multiplying a
factor 0.25 kg tissue cells dw/kg tissue cells ww [33]; for unit density, kg ww=L and mmol/kg ww=mmol/L=mM. The cytosolic and mitochondrial species
concentrations are calculated from the species concentrations in the muscle tissue cells according to their approximate volumes of distributions and mass fractions;
species nomenclature is adopted from Ref. [1] (also see the caption to Figure 1); dw denotes dry weight, ww denotes wet weight.
#The mass fractions are set to have reasonable compartmentalized species concentrations and mass action ratios consistent with available information from the
literature: Ccyt,LAC/Ccyt,PYR=16.4, Ccyt,NAD+/Ccyt,NADH=540, Cmit,NAD+/Cmit,NADH=6.3, Ccyt,PCR/Ccyt,CR=2,C cyt,ATP/Ccyt,ADP=333.2,C mit,ATP/Cmit,ADP=1.11, KLDH=(C cyt,LAC/
Ccyt,PYR)* (Ccyt,NAD+/Ccyt,NADH)=8856, KCK=(C cyt,CR/Ccyt,PCR)*(Ccyt,ATP/Ccyt,ADP)=166.6, and KAK=(C cyt,ADP)
2/(Ccyt,ATPCcyt,AMP)=1.2E-3. The cytosolic and mitochondrial PI
concentrations are set at equal value with the assumption of a negligible pH gradient across the mitochondrial membrane.
doi:10.1371/journal.pone.0003168.t001
Muscle Metabolic Dynamics
PLoS ONE | www.plosone.org 5 September 2008 | Volume 3 | Issue 9 | e3168Jbl<cyt,j~
J
p
bl<cyt,j~lbl<cyt,j Cbl,j{Ccyt,j
  
, if passive
J
f
bl<cyt,j~Tbl<cyt,j
Cbl,j
Mbl<cyt,jzCbl,j
 
{
Ccyt,j
Mbl<cyt,jzCcyt,j
 
, if facilitated
8
> > > > > > <
> > > > > > :
ð3Þ
where lbl«cyt,j is the effective permeability surface area product for
diffusive mass transport across the barrier (for passive transport);
Tbl«cyt,j is the maximal transport flux across the barrier (Tmax) and
Mbl«cyt,j is the corresponding Michaelis-Menten (M-M) constant
(Mm) (for facilitated transport). The flux expressions (3) satisfy the
thermodynamic equilibrium conditions across the barrier.
The species involved in the blood-cytosol exchange are glucose,
lactate, pyruvate, alanine, glycerol, free fatty acid, CO2,a n dO 2
(Table2).Thetransportprocessesmaybepassiveorcarrier-mediated
(facilitated) (Eq. 3). The transport of glucose, pyruvate/lactate, and
free fatty acid across the sarcolemma of skeletal muscle is facilitated
via the GLUT4 [27], MCT1 or MCT4 [28,29], and FABP or FAT/
CD36 [30] proteins, respectively. The sarcolemmal transport of the
remaining species(alanine,glycerol,CO2,a n dO 2)i sc o n s i d e r e dt ob e
passive. For the 10 species that exist in both cytosol and
mitochondria, the inter-domain transport flux Jcyt«mit,j is zero.
The lumped metabolic reactions of skeletal muscle cellular
metabolism and energetics can be considered as special cases of a
general, irreversible, multi-reactant multi-product enzymatic
reaction coupled with the metabolic energy controller pairs:
where P1 and P2 are ATP and ADP or vice-versa (PS6:
phosphorylation state); R1 and R2 are NADH and NAD
+ and
vice-versa (RS6: redox state). The corresponding coupled
phosphorylation and redox reactions are ATPRADP (PS+)
and/or NADHRNAD
+ (RS+) or vice-versa (PS- and RS-).
Assuming a phenomenological, single-step enzyme kinetic mech-
anism [31], the flux expression for the lumped metabolic reaction
can be written as (see Ref. [1] for detailed description):
w~Vmax
CP1=CP2
KPS+
m zCP1=CP2
  
CR1=CR2
KRS+
m zCR1=CR2
  
P
Ns
i~1CSi
KmzP
Ns
i~1CSi
"# ð5Þ
where Vmax and Km are the phenomenological maximal/limiting
velocity and M-M parameter of the reaction; KPS+
m and KRS+
m
are the phenomenological M-M parameters for the coupled
phosphorylation and redox reactions; CP1/CP2 is the phosphor-
ylation ratio: CATP/CADP (PS+)o rC ADP/CATP (PS-), and CR1/
CR2 is the redox ratio: CNADH/CNAD+ (RS+)o rC NAD+/CNADH
(RS-). So the reaction fluxes are explicitly regulated by the coupled
energy controller ratios CP1/CP2 and/or CR1/CR2 (if coupled).
The flux expressions for all the lumped metabolic reactions in
the subcellular compartments of cytosol and mitochondria can be
rewritten from our previous model of skeletal muscle metabolism
[1] in terms of the compartmentalized metabolites concentrations
and energy controller ratios ATP/ADP and NADH/NAD
+. The
details are provided in Materials S2.
In summary, in this mathematical model of skeletal muscle
cellular metabolism and energetics, the number of chemical
species (primary substrates, intermediate metabolites, and energy
controllers) in the tissue cells domain (cytosol and mitochondria) is
30, which participate in 26 metabolic reactions. The number of
chemical species that exist in both blood and cells is 8, and that in
both cytosol and mitochondria is 10. Accordingly, the model
includes 8 Jbl«cyt,j transport fluxes characterized by 4 l,4Tmax
and 4 Mm parameters, and 26 w reaction fluxes characterized by
26 Vmax,2 7Km (1 Km for G6P inhibition of the hexokinase
Table 2. Average muscle tissue cells uptake-release rates (mmol/min) and blood species concentrations (mM) at normal, resting
steady-state conditions from the literature.*
Species Arterial Concentrations, Cart Venous Concentrations, Cven UR rates, Q(Cart2Cven) References
GLC 5.0 4.7833 0.195 [33,38,52,54,57,59]
PYR 0.075 0.0617 0.012 [33,38,52,54,57,59]
LAC 0.5 0.6111 20.10 [33,38,52,54,57,59]
ALA 0.25 0.3333 20.075 [38,39,54,59]
GLR 0.04 0.0483 20.0075 [33,49,52,56,57,59]
FFA 0.7 0.6167 0.075 [33,49,52,56,57,59]
CO2 (T) 23.405 25.47 21.86
# (241.66 ml/min) [38,52,54,57,59]
CO2 (F) 1.22 (40 mmHg) 1.33 (43.55 mmHg) NA [25,26]
O2 (T) 9.235 6.556 2.41
# (54.0 ml/min) [38,52,54,57,59]
O2 (F) 0.135 (100 mmHg) 0.0491 (36.37 mmHg) NA [25,26]
#Physiological constrains:
URCO2~{ 6:URGLCz3:URPYRz3:URLACz3:URALAz3:URGLRz16:URFFA ðÞ
URO2~6:URGLCz2:5:URPYRz3:URLACz2:5:URALAz3:5:URGLRz23:URFFA
, RQ~{
URCO2
URO2
~0:77
.
*A resting blood flow of 0.9 L/min corresponding to the two-leg quadriceps femoris muscle is used to calculate the muscle tissue cells uptake-release (UR) rates from the
arterio-venous (AV) differences. The venous species concentrations and uptake-release rates are tuned further to satisfy the physiological constrains
# stated above, just
below the table. (These well-compiled data are adapted from Table 2, Ref. [1].)
doi:10.1371/journal.pone.0003168.t002
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m and 11KRS+
m
parameters (as in our previous model [1]). Besides, there are 10
partition coefficients s for the chemical species that exists in both
cytosol and mitochondria (since the 10 Jcyt«mit,j transport fluxes are
considered negligible). Therefore, the present model is character-
ized by a total of 99 unknown parameters that need to be
estimated to fit the model outputs to the available in vivo
experimental data. For convenience, the transport and reaction
fluxes are written here in vector form: ~ J J~~ J J ~ C C;~ l l,~ T Tmax,~ M Mm
  
and
~ w w~~ w w ~ C C; ~ V Vmax,~ K Km,~ K KPS+
m ,~ K KRS+
m
  
, where the parameter vector
for these transport and reaction fluxes is denoted by
~ h h~ ~ l l,~ T Tmax,~ M Mm,~ s s,~ V Vmax,~ K Km,~ K KPS+
m ,~ K KRS+
m
  
; ~ C C is the concentra-
tion vector. Note that the 12 transport parameters (4 l,4Tmax and
4 Mm) can be estimated here uniquely from the resting, steady-
state transport flux-concentration relationships (Table 3) [1]. The
10 partition coefficients (10 s) can be estimated uniquely from the
resting, steady-state species concentration ratios between the
mitochondria and cytosol (sj=Cmit,j/Ccyt,j) (Table 3).
Model simulation
With specified parameter values, the mathematical model is
solved numerically to simulate dynamic responses of the system to
ischemia produced by reducing muscle blood flow. Typically, the
initial conditions: Cbl,j tƒ0 ðÞ ~C0
bl,j, Ccyt,j tƒ0 ðÞ ~C0
cyt,j, and
Cmit,j tƒ0 ðÞ ~C0
mit,j are assumed to be at a normal, resting
steady-state. These are fixed based on average resting species
concentrations gathered from various literature sources on skeletal
muscle cellular metabolism that are consistent with the resting,
steady-state flux-concentration relationships (Tables 1 and 2). The
species mass fractions and volumes of distributions in the
subcellular cytosolic and mitochondrial domains are set to have
appropriate phosphorylation and redox potentials in the cytosol
and mitochondria. For numerical solution of this stiff initial-value
problem, a robust implicit integrator DLSODES (https://
computation.llnl.gov/casc/odepack/odepack_home.html; http://
www.netlib.org/odepack; [32]) is used. Specifically, the Gear’s
implicit integration method based on backward difference formula
(BDF) is most suitable for this problem. An absolute and relative
error of tolerance of 10
210 guarantees high accuracy and
convergence of the iterative solutions of the ODEs. The
DLSODES solver is usually very fast; a typical simulation of this
problem using the DLSODES solver in a standard desktop
computer (Intel Xeon or Core 2 Duo CPU 5160 @ 3 GHz) takes
only about 5 seconds of the CPU time. As a check, the numerical
solutions of the initial value problem were also obtained using the
ODE15S solver in MATLAB (http://www.mathworks.com) with
Table 3. Optimal model parameter values for the inter-domain transport fluxes determined from the steady-state parameter
estimation process.
I. Blood-cytosol passive or carrier-mediated (facilitated) transport fluxes (mmol/min) and parameters:
J
p
bl<cyt,j~lbl<cyt,j Cbl,j{Ccyt,j
  
or J
f
bl<cyt,j~Tbl<cyt,j
Cbl,j
Mbl<cyt,jzCbl,j {
Ccyt,j
Mbl<cyt,jzCcyt,j
  
Species lbl«cyt (ml/min) Tbl«cyt (mmol/min) Mbl«cyt (mmol/L) Jbl«cyt (mmol/min)
GLC N/A 0.4106 2.5 [27] 0.195
PYR N/A 1.5127 1.0 [28,29] 0.012
LAC N/A 2.5769 5.0 [28,29] 20.10
ALA 0.0675 N/A N/A 20.075
GLR 0.3142 N/A N/A 20.0075
FFA N/A 1.5589 1.0 0.075
CO2 24.926 N/A N/A 21.86
O2 157.1 N/A N/A 2.41
II. Cytosol-mitochondrial species partition coefficients (unitless): scyt«mit,j=Cmit,j/Ccyt,j
Species PYR FAC CoA PI ATP ADP NADH NAD
+ O2 CO2
scyt«mit,j 0.4737 0.4737 2.25 1.0 1.465 441.0 1791.0 21.0 1.0 1.0
III. Anatomical volumes and muscle blood flow
Parameter Definition Value and Unit Reference
Vmus Total volume of the active muscle 4.0 kg wet weight (L) estimated
(Vbl,Visf, Vcyt, Vmit) Volumes of blood, ISF, cytosol and mitochondria (0.07Vm, 0.13Vm, 0.72Vm, 0.08Vm) calculated
Q Muscle blood flow at rest for two legs 0.9 L/min [33,57,59]
Qisch Muscle blood flow during ischemia 0.216 L/min estimated
The table also includes the anatomical volumes and muscle blood flow at rest (fixed) and during muscle ischemia (estimated).*
*The blood-cytosol transport fluxes satisfies Jbl«cyt,j=URj=Q(Cart,j2Cven,j) at resting, steady-state (the UR rates column in Table 2). The subcellular cytosolic and
mitochondrial domains are assumed to be in rapid equilibrium state so that the cytosol-mitochondria transport fluxes are considered negligible and the metabolites
common to both of these domains are considered to have the similar dynamics (i.e., Cmit,j(t)=sj.Ccyt,j(t)). Thus the cytosol-mitochondria metabolites partition
coefficients sj are calculated based on the resting, steady-state metabolite concentrations in these two subcellular domains. The estimates of the transport flux
parameters differ from those obtained in our previous work [1] because of the re-estimation of these parameters due to subcellular compartmentalization.
doi:10.1371/journal.pone.0003168.t003
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accuracy with that obtained using the DLSODES solver.
Parameter Estimation
The large number of unknown parameters of this model are
estimated by comparing model outputs to in vivo experimental data
of Katz [22] with the optimization procedure described previously
[1]. The data consist of key metabolites concentration dynamics
measured during circulatory occlusion and recovery (reperfusion)
in human skeletal muscle at the whole tissue-organ level [22].
Specifically, the data is based on the biopsy measurements of
glucose and glycolytic/glycogenolytic intermediates (i.e., glucose 6-
phosphate, pyruvate, and lactate) and creatine and high-energy
phosphates (i.e., phosphocreatine, inorganic phosphate, ATP,
ADP, and AMP) in quadriceps femoris muscle tissue at rest, after
30 minutes of ischemia, and after 15 minutes of reperfusion. The
tissue metabolite contents or concentrations were measured in the
units of mmol/kg dry weight. For our analysis, these concentra-
tions are converted to the units of mmol/kg wet weight (mmol/L
or mM) by multiplying a conversion factor of 0.25 kg dry weight/
kg wet weight, corresponding to the muscle tissue [33]. Consistent
with the experimental measurements of Katz [22], the following
ischemia protocol is used for model simulations and parameter
estimation: the muscle blood flow is reduced from Q=0.9 L/min
at rest (t,0 min) to Q=Qisch (unknown) at the onset of ischemia
(0#t#30 min), and then increased to the starting level at the onset
of recovery (t.30 min). The active muscle volume (Vmus) and
ischemic muscle blood flow (Qisch) responsible for the predicted
metabolic dynamics in skeletal muscle during ischemia and
recovery were not known from the experimental study of Katz
[22]. Therefore, Vmus and Qisch are also included as the unknown
parameters for estimation, making the total number of unknown
parameters in the model to 101. This is an increase of 10 unknown
parameters (10 s) from our previous model [1].
With this relatively sparse data and large number of unknown
parameters, the parameter estimation problem is ill-conditioned
and under-determined. Nevertheless, an efficient estimation
method is devised based on our earlier work [1] to obtain
physiologically reasonable parameter values that minimize the
sum of squared differences between the available experimental
data and corresponding model outputs. The estimation procedure
proceeds in two main stages. In the first stage, the published
normal, resting species concentration data (Tables 1 and 2) are
used to evaluate the resting transport and reaction fluxes from a
steady-state flux balance analysis (Tables 2, 3 and 4). From the
resting flux-concentration relationships: Eqs. (3) and (5), the
preliminary estimates of the transport and reaction parameters are
obtained. The preliminary estimates of the 10 partition coefficients
are obtained from the resting, steady-state species concentration
ratios between mitochondria and cytosol (sj=Cmit,j/Ccyt,j) (Table 3).
In the second stage, the dynamic species concentration data [22]
together with the resting, steady-state flux balance equations as
equality constraints are used to obtain the optimal parameter
estimates (Tables 3 and 4).
A detailed description of this robust estimation approach for
obtaining optimal parameter estimates from species concentration
dynamics during muscle ischemia and recovery is presented in
Ref. [1]. This method has been established powerful in the analysis
of large-scale in vivo metabolic systems. The efficiency and
robustness of this parameter estimation approach was tested with
parameter sensitivity analysis as well as with repeated parameter
estimation with various initial parameter estimates (initial guesses).
Various estimates of the more sensitive model parameters spanned
in a small neighborhood of the optimal parameter estimates (see
Ref. [1] for details). Since the preliminary estimates of the 12
transport parameters and 10 partition coefficients based on the
resting species concentrations and transport fluxes were accurate
enough, these 22 parameters were not re-estimated from the
dynamic species concentration data. Therefore, as in our previous
paper [1], a total of 101–22=79 parameters (77 reaction
parameters+Vmus+Qisch) are effectively estimated from the dynamic
data.
Results
Comparison of model simulations with experimental
data
The optimal estimates of the transport parameters (l,Tmax,Mm),
partition coefficients (s), active muscle volume and ischemic
muscle blood flow (Vmus, Qisch), and reaction parameters
Vmax, Km, KPS+
m , KRS+
m
  
for the model are shown in Tables 3
and 4. These parameter estimates yield the best fit of the model
outputs to the published experimental data [22] with minimal
residual errors and minimal objective function. The optimal
estimates of Vmus and Qisch corresponding to the experimental data
were ,4.0 L (,16% of normal two-legs muscle volume of ,25 L)
and ,0.216 L/min (,76% reduction from normal, resting two-
legs muscle blood flow of Q=0.9 L/min). These optimal
parameter values were used for model simulations during the
resting, ischemia and recovery periods. The blood flow reduction
levels of Qisch=0.18, 0.27 and 0.36 L/min (80%, 70% and 60%)
were used for simulating severe to moderate to mild ischemic
conditions.
The correspondence of model simulations and experimental
data is demonstrated through Figures 3 and 4. Specifically, shown
are the concentration dynamics of 4 glycolytic metabolites (GLC,
G6P, LAC, PYR) and 6 energy metabolites (PCR, CR, PI, ATP,
ADP, AMP) in the muscle tissue cells (i.e., weighted volume
averages of concentrations in cytosol and mitochondria) for which
experimental data were available [22] for four different blood flow
reduction levels Qisch=0.18, 0.216, 0.27 and 0.36 L/min. Figure 3
also includes the concentration dynamics of NADH and NAD
+ in
the muscle tissue cells. The dynamics of compartmentalized
cytosolic and mitochondrial phosphorylation and redox potentials
(i.e., [ATP]/[ADP] and [NAD
+]/[NADH] ratios) and cytosolic
[LAC]/[PYR] and [PCR]/[CR] ratios are shown in Figure 5.
The level Qisch=0.216 L/min corresponds to the experimental
data of Katz [22] and the corresponding model simulations match
to the data reasonably well within the experimental noise (Table 5).
The experimental data are normalized here with respect to the
resting metabolites concentrations (control). Furthermore, the
individual metabolites responses are shown in separate plots in
order to distinguish metabolite responses to different levels of
blood flow reductions.
The model simulations of cellular glucose (GLC), glucose-6-
phosphate (G6P), pyruvate (PYR), and lactate (LAC) concentra-
tions at the end of 76% ischemia and reperfusion are in close
agreement with the experimental data (Fig. 3(A–D), Table 5).
Cellular [G6P] increased quickly (exponentially) by ,60% during
ischemia and returned rapidly to its resting level at the onset of
reperfusion. In contrast, the cellular [GLC] increased slowly
(almost linearly) by ,35% during ischemia and remained at an
elevated level even after 30 minutes of reperfusion. Blood [GLC],
however, decreased rapidly, but only by ,10%, during ischemia
and returned quickly to its baseline value during reperfusion (not
shown). Furthermore, the model-predicted changes in the cellular
[G6P] and [GLC] during the mild 60% and 70% blood flow
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changes during the high 76% and above (i.e., 80%) blood flow
reduction levels.
Both cellular [LAC] and [PYR] increased by ,125% during
76% ischemia and almost returned to the resting levels after
30 minutes of reperfusion. However, the dynamic response of
[PYR] was different from that of [LAC]. During ischemia, [PYR]
first decreased and then increased, but during reperfusion, [PYR]
first sharply increased and then rapidly decreased to the resting
level. On the other hand, [LAC] slowly (almost linearly) increased
during ischemia and slowly (almost linearly) decreased during
reperfusion. Blood [LAC] had the similar dynamics as that of
cellular [LAC] (not shown). These differential dynamics of cellular
[LAC] and [PYR] characterize the dynamics of cellular or
cytosolic [LAC]/[PYR] ratio. The dynamics of cytosolic [LAC]/
[PYR] ratio and cytosolic and mitochondrial redox states
([NADH] and [NAD
+]) and redox potentials ([NAD
+]/[NADH]
ratios) were all similar having biphasic behaviors during the
ischemia and reperfusion periods (Figs. 3(E,F) and 5(A–C)). This is
in contrast to our previous model (in which the cytosolic and
mitochondrial compartments were lumped into a single tissue cells
compartment [1]) predictions that the dynamic responses of
cellular [LAC]/[PYR] and [NAD
+]/[NADH] ratios to ischemia
and reperfusion are distinct. Thus the present compartmentalized
model is able to correctly simulate the dynamic responses of
cytosolic and cellular [LAC]/[PYR] ratios as well as cytosolic and
mitochondrial [NAD
+]/[NADH] ratios. The cytosolic [LAC]/
[PYR] ratio rapidly increased from a resting level of ,16.4 to
,26.8 at the onset of 76% ischemia, then quickly decreased
almost to the baseline value (,17.22) as ischemia progressed, in
agreement with the data (Table 5). In contrast, the cytosolic
[NAD
+]/[NADH] ratio decreased quickly from a resting level of
,540 to ,265 at the onset of 76% ischemia, then increased and
reached a new steady state value of ,332 as ischemia progressed.
The LDH mass action ratio ([LAC][NAD
+])/([PYR][NADH])
decreased considerably from a resting level of ,8856 to ,5585
during 76% ischemia. At different levels of blood flow reductions,
the model-predicted changes were not proportional. The changes
were negligible below 70% blood flow reduction levels and
significant above 76% blood flow reduction levels.
Table 4. Resting, steady-state metabolic reaction flux rates and corresponding optimal estimates of the Vmax, Km, KPS+
m and
KRS+
m parameters that govern the metabolic reaction flux rates.*
Metabolic Reactions Flux rates (mmol/min) Vmax (mmol/min) Km (mmol/L)
n K
PS6
m (unitless) K
RS6
m (unitless)
1. Glucose Utilization 0.195 1.1171 6.9E-2, 0.224
## 334.13 (+)0
2. Glycogen Synthesis 0.25
# 0.8006 0.1641 337.69 (+)0
3. Glycogen Utilization 0.25
# 50.371 307.178 0.7473 (2)0
4. G6P Breakdown 0.195 39.615 27.778 337.055 (+)0
5. GA3P Breakdown 0.3825 43.331 14.354 0 540.233(2)
6. Pyruvate Production 0.3825 959.85 2.1199 0.3002 (2)0
7. Pyruvate Reduction 25
# 101.707 0.1575 0 3.904E-05(+)
8. Lactate Oxidation 24.9
# 3494.12 59.988 0 539.170 (2)
9. Alanine Production 0.075 7.5752 5.2779 0 0
10. TGL Synthesis 0.0075 5.7349 3.214E-2 0 1.25E-2 (+)
11. Lipolysis 0.0075 1.516E-2 17.029 0 0
12. FFA Activation 0.0975 19.705 0.8896 333.08 (+)0
13. ATP Hydrolysis 15.217 35.961 15.967 333.14 (+)0
14. PCR Breakdown 100
# 19822.6 22.091 0.3025 (2)0
15. PCR Synthesis 100
# 202.01 0.1142 333.425 (+)0
16. AMP Utilization 50
# 254.64 6.872E-02 333.297 (+)0
17. AMP Production 50
# 2064.73 1.214E-02 7.063E-2 (2)0
18. Pyruvate Oxidation 0.2195 0.5043 1.441E-04 0 6.383 (2)
19. FAC Oxidation 0.075 25.995 1.197E-2 0 6.430 (2)
20. Citrate Production 0.8195 83.932 6.085E-2 0 0
21. AKG Production 0.8195 3.7097 1.273 0 5.917 (2)
22. SCoA Production 0.8195 161.242 0.5007 0 5.987 (2)
23. Succinate Production 0.8195 3.1152 2.5616 0.4755 (2)0
24. Malate Production 0.8195 1.6616 2.024E-02 0 6.238 (2)
25. Oxaloacetate Production 0.8195 1.9415 7.964E-02 0 7.509 (2)
26. Oxygen Utilization 2.41125 258.154 7.696E-04 5.1083 (2) 2.341(+)
*The metabolic reaction flux rates are calculated based on resting, steady-state flux balance analysis (see Table 3, Ref. [1], for details). The flux rates with ‘‘#’’ can not
be determined uniquely, and hence are set at values consistent with the other flux values (e.g., set a large value for the fast equilibrium reversible reactions like CK,
AK and LDH). For K
PS6
m and K
RS6
m parameters, ‘‘+’’ indicates that the energy controller ratio is CATP/CADP or CATP/CAMP or CNADH/CNAD+,‘ ‘ 2’’ indicates that the energy
controller ratio is CADP/CATP or CAMP/CATP or CNAD+/CNADH, and ‘‘0’’ indicates that no controller ratio appears in the flux expression; ## denotes the estimated Km value
KG6P
GLC?G6P
  
for the inhibition of hexokinase reaction by G6P.
doi:10.1371/journal.pone.0003168.t004
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(CR), and inorganic phosphate (PI) concentrations at the end of 76%
ischemia and recovery are in good agreement with the experimental
data (Fig. 4(A–C)). After 30 minutes, 76% ischemia resulted in
,1 7 . 5 %d e c r e a s ei nm u s c l eP C Rc o n t e n t ,w h i c hw a sf u l l y
resynthesized after 30 minutes of recovery. Muscle CR and PI
contents increased by ,35% and ,130%, respectively, at the end of
76% ischemia and returned to their resting levels at the end of
recovery. The dynamics of [PCR] drop during ischemia and rise
during recovery were exponential, but faster during the recovery
period. The dynamics of both [CR] and [PI] show the opposite
trends (both are mirror images of [PCR] having the similar time
constants). The cytosolic [PCR]/[CR] ratio decreased substantially
fromarestingvalueof,2t o,1.2duringischemia(Fig.5D,Table5).
The model-predicted muscle [PCR], [CR], [PI] and [PCR]/[CR]
ratio during the mild 60% and 70% blood flow reduction levels did
not change appreciably from their baseline, resting levels.
The model-simulated muscle [ATP] decreased slightly during
ischemia which resulted in appropriate increases in muscle [ADP]
and [AMP] (Fig. 4(D–F)). A 76% blood flow reduction resulted in
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Figure 3. Model-predicted dynamic responses of glycolytic metabolite concentrations and redox states in the muscle tissue cells
during the resting, ischemia and recovery periods with varying levels of blood flow reduction and their comparison to the
experimental data of Katz [22]. The responses were computed using the estimated optimal parameter values with the ischemia protocol of 25t o
0 min of resting, 0 to 30 min of ischemia, and 30 to 60 min of recovery. The muscle blood flow Q is reduced as a step from 0.9 L/min at rest to
Qisch=0.36, 0.27, 0.216, 0.18 L/min at the onset of ischemia and returned to 0.9 L/min at the onset of recovery. The lines represent the model
simulation results with the symbols representing the experimental data points (mean6SD) corresponding to Qisch=0.216 L/min (,76% blood flow
reduction). The metabolites concentrations are shown in normalized form, normalized with respect to the resting metabolites concentrations. The
concentrations in the tissue cells are calculated based on the formula: Ccl=(VcytCcyt+VmitCmit)/Vcl.
doi:10.1371/journal.pone.0003168.g003
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accordance with the data. The cytosolic and mitochondrial
phosphorylation potentials ([ATP]/[ADP] ratios) had the similar
dynamics as of the cytosolic [PCR]/[CR] ratio (Fig. 5(D–F)).
However, the magnitude of [ATP]/[ADP] decrease (,6%) during
ischemia was negligible in comparison to the magnitude of
[PCR]/[CR] decrease (,40%). The CK mass action ratio
([CR][ATP])/([PCR][ADP]) increased from a resting value of
,166 to ,260 during the peak ischemia. The total adenylate
nucleotide pool (TAN=[ATP]+[ADP]+[AMP]) was maintained
at a constant level of ,7.0 mM in accordance with the data
(Table 5). The model-predicted changes in muscle [ATP], [ADP],
[AMP], and [ATP]/[ADP] ratio during the mild 60% and 70%
blood flow reduction conditions were negligible. Thus, in contrast
to our previous model [1], the present compartmentalized model is
able to simulate the dynamic responses of cytosolic and cellular
[PCR]/[CR] ratios as well as cytosolic and mitochondrial [ATP]/
[ADP] ratios appropriately.
Simulated dynamics of mitochondrial metabolites
The model-simulated dynamic responses of mitochondrial FAC,
ACoA, CIT, AKG, SCoA, SUC, MAL and OXA during the
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Figure 4. Model-predicted dynamic responses of energy metabolite concentrations in the muscle tissue cells during the resting,
ischemia and recovery periods with varying levels of blood flow reductions and their comparison to the experimental data of Katz
[22]. The lines represent the model simulation results with the symbols representing the experimental data points (mean6SD) corresponding to
Qisch=0.216 L/min (,76% blood flow reduction). The simulation strategy, ischemia protocol, and blood flow reduction levels are exactly the same as
those described in the caption of Figure 3. The metabolites concentrations are shown in normalized form, normalized with respect to the resting
metabolites concentrations. The concentrations in the tissue cells were calculated based on the formula: Ccl=(VcytCcyt+VmitCmit)/Vcl.
doi:10.1371/journal.pone.0003168.g004
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80%, 76%, 70% and 60% (Qisch=0.18, 0.216, 0.27 and 0.36 L/
min) are shown in Figure 6. Experimental data were not available
for these key mitochondrial and TCA cycle intermediate
metabolites. In fact, due to the limitations in the available
experimental techniques, most of these subcellular metabolites can
not be measured conveniently in skeletal muscle tissue cells in vivo
at the whole tissue-organ level. However, the present compart-
mentalized model is able to simulate the dynamic responses of
these subcellular metabolites to physiological stresses such as
muscle ischemia. Model simulations show that the changes in these
metabolites concentrations during muscle ischemia are not simply
proportional to the extent of blood flow reduction. The changes
are negligible during the mild 60% and moderate 70% blood flow
reduction levels, but significant above the severe 76% blood flow
reduction level.
The model-simulated dynamic responses of mitochondrial and
TCA cycle intermediate metabolites to muscle ischemia differ
from each other (Figure 6). During ischemia, the mitochondrial
[ACoA], [SUC] and [MAL] were increased, while [CIT], [AKG]
and [SCoA] were decreased. Furthermore, the accumulation of
ACoA was very significant (,45 fold increase in [ACoA] with
76% blood flow reduction), in spite of a large decrease in
mitochondrial redox ratio [NAD
+]/[NADH]. The accumulation
of ACoA is primarily attributed to a biphasic increase in free
[CoA] and a sharp 80-fold decrease in [OXA] (Fig. 6H) resulting
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Figure 5. Model-predicted dynamic responses of cytosolic [LAC]/[PYR] and [PCR]/[CR] ratios and cytosolic and mitochondrial [ATP]/
[ADP] and [NAD
+]/[NADH] ratios during the resting, ischemia and recovery periods with varying levels of blood flow reductions.
The simulation strategy, ischemia protocol, and blood flow reduction levels are exactly the same as those described in the caption of Figure 3.
doi:10.1371/journal.pone.0003168.g005
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ACoA in the mitochondria. The decreases in [SCoA] and
increases in [SUC] are in accordance with the increases in
mitochondrial phosphorylation ratio [ADP]/[ATP]. However, the
decreases in [CIT] and [AKG] and increases in [MAL] were not
consistent with the increases in mitochondrial redox ratio
[NAD
+]/[NADH]. The TCA cycle reaction fluxes decreased
from a resting level of ,0.82 to ,0.62 mmol/min (,25%) with a
76% blood flow reduction (not shown).
Simulated dynamics of fluxes of exchangeable substrates
The model-simulated dynamic responses of transport and
reaction rates associated with the blood-tissue cells exchangeable
substrates (i.e., glucose, lactate, pyruvate, free fatty acid, CO2, and
O2) during the resting steady-state (t,0 min), ischemia
(0#t#30 min), and recovery (t.30 min) periods with a blood
flow reduction level of 76% (Qisch=0.216 L/min) are shown in
Figure 7. The corresponding capillary blood (venous blood) and
tissue cells levels of O2 and CO2 are shown in Figure 8. The
transport rates include the species net uptake/release rates
(URj=Q(Cart,j2Cven,j)) and net blood-tissue cells exchange rates
Jbl<cyt,j~J
p
bl<cyt,j or J
f
bl<cyt,j
  
. The reaction rates include the
species net production/utilization rates (Rcl,j=Pcl,j2Ucl,j) in the
tissue cells (cytosol and/or mitochondria). Most of these model
predictions are similar to those from our previous model [1] which
do not account for the intracellular compartmentalization. The
magnitudes of changes with the present compartmentalized
model, however, are lower and consistent with the lower estimate
of the blood flow reduction level during muscle ischemia (present
Qisch=0.216 vs. previous Qisch=0.135).
Figure 7A shows that the net muscle glucose uptake (URGLC)
changes sharply (decreases/increases) at the onset of ischemia/
recovery due to a step change (decrease/increase) in muscle blood
flow, while the net glucose uptake by muscle tissue cells (Jbl«cyt,GLC)
remains fairly constant during ischemia and recovery. This results
in a fast adjustment (decrease/increase) in the venous glucose
concentration and glucose A–V difference and a rapid recovery in
muscle net glucose uptake. The net glucose utilization
(Ucl,GLC2Pcl,GLC) through the hexokinase reaction decreases/
increases quickly during ischemia/recovery due to the increase/
decrease of [G6P] and G6P inhibition of hexokinase reaction. This
is reflected in the predicted elevated cellular [GLC] during
recovery (Fig. 3A). Several inhibition mechanisms of hexokinase
reaction by G6P were tested. A general uncompetitive inhibition
mechanism, which effectively modifies the Km as well as Vmax of the
reaction [23,31], was found to be the most suitable for the model
to fit to the data.
The net pyruvate UR and Jbl«cyt rates are closely matched
where both decrease/increase during ischemia/recovery, except at
the onset of recovery, where URPYR and Jbl«cyt,PYR rates first
sharply decrease and then exponentially increase to the baseline
level (Fig. 7B, dashed and dotted lines). The pyruvate metabolism
switches from a net utilization to a net production and a net uptake
to a net release during ischemia and vice-versa during recovery (as
depicted through the solid line in Fig. 7B). Similar to pyruvate, the
net UR and Jbl«cyt rates of lactate were approximately matched,
through the 2Jbl«cyt,LAC rate was slightly higher than the 2URLAC
rate during ischemia and vice-versa during recovery (Fig. 7C,
dashed and dotted lines). However, the net lactate release
(2URLAC and 2Jbl«cyt,LAC) first decreases when muscle blood flow
is reduced and then increases steadily (linearly) slightly above the
baseline value during the remaining ischemic period. During
recovery, the opposite, but more pronounced, trend occurs. The
net lactate production (Pcl,LAC2Ucl,LAC) increased quickly at the
onset of ischemia and reached a new steady-state level within the
first 10 minutes of ischemia. At the onset of recovery, the net
lactate production decreased quickly to the baseline value (solid
line, Fig. 7C).
Figure 7D shows that the net UR and Jbl«cyt rates of free fatty
acid (FFA) decreased quickly at the onset of ischemia and then
Table 5. Model simulation results compared with the experimental data of Katz [22] on muscle ischemia.*
Species or
Species Ratio
Concentration Data
(mM) (t=0 min)
(mean6SD)
Concentration
Model (mM)
(t=0 min)
Concentration Data
(mM) (t=30 min)
(mean6SD)
Concentration
Model (mM)
(t=30 min)
Concentration Data
(mM) (t=45 min)
(mean6SD)
Concentration
Model (mM)
(t=45 min)
GLC 0.48560.0575 0.485 0.65760.0925 0.676 0.65360.0925 0.630
G6P 0.2460.04 0.24 0.37560.06 0.379 0.28560.037 0.252
PYR 0.042560.006 0.0425 0.092560.0075 0.0918 0.052560.0075 0.057
LAC 0.68860.12 0.688 1.53560.38 1.545 0.9460.12 0.850
LAC/PYR
# 16.262.9 16.2 16.664.1 16.8 17.962.2 14.9
PCR 20.160.65 20.1 16.5561.175 16.55 20.22560.6 19.94
CR 10.4560.7 10.45 14.061.1 14.12 10.32560.7 10.62
PCR/CR
# 1.9760.12 1.97 1.3560.13 1.17 2.0360.15 1.88
Pi 2.70 2.7 6.2560.8 6.2 2.660.3 2.845
ATP 6.1560.175 6.15 6.22560.15 6.092 6.260.175 6.148
ADP 0.8260.025 0.82 0.88560.04 0.869 0.85560.035 0.822
AMP 0.0460.005 0.04 0.0560.007 0.0494 0.04260.006 0.0403
TAN 7.060.175 7.01 7.0560.125 7.01 7.160.175 7.01
*The model simulation are based on the ischemia protocol of Katz [22]: if (t,0 min | t.30 min) Q=0.9 L/min, else Q=Qisch=0.216 L/min. The species concentrations
(mM or mmol/kg ww) are converted from the experimental data (mmol/kg dw) by multiplying a factor 0.25 kg dw/kg ww [33]. For unit density, kg ww=L and mmol/kg
ww=mmol/L=mM. The species concentrations are based on 100% muscle tissue cells, i.e., the volume averages of species concentrations in the cytosol and
mitochondria, Ccl=(VcytCcyt+VmitCmit)/Vcl. The species concentrations in the model are scaled with the resting (t=0) species concentrations in the data (i.e.,
Cmodel
j ti ðÞ :Cdata
rest,j
.
Cmodel
rest,j ) for comparison purpose; ‘‘dw’’ means dry weight and ‘‘ww’’ means wet weight.
#Concentration ratios [LAC]/[PYR] and [PCR]/[CR] are unitless.
doi:10.1371/journal.pone.0003168.t005
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(biphasic behavior); the opposite trend occurred during the
recovery period. The net utilization of FFA (Ucl,FFA2Pcl,FFA) had
exactly the opposite behavior of URFFA and Jbl«cyt,FFA rates. The
dynamics of CO2 release and FFA uptake were similar (dashed
and dotted lines, Fig. 7(D,E)). However, the CO2 production was
closely correlated to the O2 consumption (solid lines, Fig. 7(E,F)).
The muscle O2 uptake, cellular O2 uptake, and cellular O2
consumption were all reduced during the ischemia period and
were closely matched (all reduced by ,22% during 76%
ischemia), except at the onset of ischemia and recovery, where
the muscle O2 uptake decreased/increased sharply with the step
change (decrease/increase) in muscle blood flow and returned to
the new steady state levels as ischemia progressed (Fig. 7F). The
O2 partial pressure (PO2) in the muscle tissue cells decreased from
25 mmHg to ,0.5 mmHg (i.e., about the Km value for O2
consumption), while the corresponding CO2 partial pressure
(PCO2) increased from 46 mmHg to ,52 mmHg during the 76%
ischemia period (Fig. 8(B,D)). Accordingly, the total O2 content in
the capillary blood (venous blood) decreased from ,6.6 mM
•5 0 15 30 45 60
0.5
0.7
0.9
1.1
1.3
Time, t [min]
C
F
A
C
(
t
)
 
/
 
C
F
A
C
(
t
 
=
 
0
)
 
i
n
 
C
e
l
l
s
•5 0 15 30 45 60
0
15
30
45
60
Time, t [min]
C
A
C
o
A
(
t
)
 
/
 
C
A
C
o
A
(
t
 
=
 
0
)
 
i
n
 
C
e
l
l
s
•5 0 15 30 45 60
0.9
0.95
1
1.05
Time, t [min]
C
C
I
T
(
t
)
 
/
 
C
C
I
T
(
t
 
=
 
0
)
 
i
n
 
C
e
l
l
s
•5 0 15 30 45 60
0.3
0.6
0.9
1.2
1.5
Time, t [min]
C
A
K
G
(
t
)
 
/
 
C
A
K
G
(
t
 
=
 
0
)
 
i
n
 
C
e
l
l
s
•5 0 15 30 45 60
0
0.3
0.6
0.9
1.2
Time, t [min]
C
S
C
o
A
(
t
)
 
/
 
C
S
C
o
A
(
t
 
=
 
0
)
 
i
n
 
C
e
l
l
s
•5 0 15 30 45 60
0.5
1
1.5
2
2.5
Time, t [min]
C
S
U
C
(
t
)
 
/
 
C
S
U
C
(
t
 
=
 
0
)
 
i
n
 
C
e
l
l
s
•5 0 15 30 45 60
0.9
1
1.1
1.2
1.3
Time, t [min]
C
M
A
L
(
t
)
 
/
 
C
M
A
L
(
t
 
=
 
0
)
 
i
n
 
C
e
l
l
s
•5 0 15 30 45 60
0
0.3
0.6
0.9
1.2
Time, t [min]
C
O
X
A
(
t
)
 
/
 
C
O
X
A
(
t
 
=
 
0
)
 
i
n
 
C
e
l
l
s
Q
isch = 0.36
        = 0.27
        = 0.216
        = 0.18
Q
isch = 0.36
        = 0.27
        = 0.216
        = 0.18
Q
isch = 0.36
        = 0.27
        = 0.216
        = 0.18
Q
isch = 0.36
        = 0.27
        = 0.216
        = 0.18
Q
isch = 0.36
        = 0.27
        = 0.216
        = 0.18
Q
isch = 0.36
        = 0.27
        = 0.216
        = 0.18
Q
isch = 0.36
        = 0.27
        = 0.216
        = 0.18
Q
isch = 0.36
        = 0.27
        = 0.216
        = 0.18
Figure 6. Model-predicted dynamic responses of FAC, ACoA, and TCA cycle intermediate concentrations in the muscle tissue cells
mitochondria during the resting, ischemia and recovery periods with varying levels of blood flow reduction. The simulation strategy,
ischemia protocol, and blood flow reduction levels are exactly the same as those described in the caption of Figure 3. The metabolites concentrations
are shown in normalized form, normalized with respect to the resting metabolites concentrations. The concentrations in the tissue cells were
calculated based on the formula: Ccl=(VcytCcyt+VmitCmit)/Vcl.
doi:10.1371/journal.pone.0003168.g006
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content in the blood increased from ,25.5 mM (,43.6 mmHg)
to ,29.6 mM (,51 mmHg) (Fig. 8(A,C)). These model simula-
tions indicate that the muscle tissue cells were hypoxic during the
76% ischemia period; the reduced O2 consumption was
maintained by the reduced O2 supply during ischemia.
Simulated dynamics of fluxes associated with ACoA and
ATP
The model-simulated dynamic responses of metabolic fluxes
associated with the production and utilization of ACoA and ATP
during the resting steady-state (t,0 min), ischemia (0#t#30 min)
and recovery (t.30 min) periods with a blood flow reduction level
of 76% (Qisch=0.216 L/min) are shown in Figure 9. Specifically,
Figures 9A and 9B show the relative contributions from
carbohydrates (PYR) and fats (FAC) to the production of ACoA
in mitochondria, and the dynamics of ACoA utilization to CIT
production in the mitochondrial TCA cycle. Figures 9C and 9D
depict the utilization rate of ATP through ATP hydrolysis in
cytosol and production rate of ATP through oxidative phosphor-
ylation (O2 consumption) in mitochondria and creatine kinase
buffer reaction in cytosol.
Figure 7. Model-predicted dynamic responses of transport and metabolic fluxes of glucose, pyruvate, lactate, free fatty acid,
oxygen, and carbon dioxide during the resting, ischemia and recovery periods with a blood flow reduction of about 76%. The
responses were computed using the estimated optimal parameter values with the ischemia protocol of 25 to 0 min of resting, 0 to 30 min of
ischemia, and 30 to 60 min of recovery. The muscle blood flow Q is reduced as a step from 0.9 L/min at rest to Qisch=0.216 L/min at the onset of
ischemia and returned to 0.9 L/min at the onset of recovery. Q(Ca–Cv): uptake-release rates, Jb«c: blood-tissue cells transport rates, Pc–Uc: tissue cells
production-utilization rates.
doi:10.1371/journal.pone.0003168.g007
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PLoS ONE | www.plosone.org 15 September 2008 | Volume 3 | Issue 9 | e3168The production of mitochondrial ACoA from PYR decreased
rapidly at the onset of ischemia and then increased relatively
slowly to reach a new steady-state level as ischemia progressed
(biphasic behavior). During recovery, the trend was opposite
(Fig. 9A, dashed line). The production of mitochondrial ACoA
from FAC varied relatively little during the entire ischemic and
recovery periods (Fig. 9B, dotted line). An increase in total
production of ACoA from PYR and FAC occurred at the beginning
of ischemia due to a transient increase in the mitochondrial fatty
acid b-oxidation. However, as ischemia progressed, ACoA
production decreased and reached a new steady-state level
significantly below its baseline value (Fig. 9B, solid line). In contrast,
the utilization of ACoA to produce CIT decreased at the onset of
ischemia and then increased to match the total ACoA production
from PYR and FAC (Fig. 9B, dashed-dotted line). A mismatch
between the total production and utilizationof ACoAat the onset of
ischemia is reflected in the predicted mitochondrial accumulation of
ACoA during ischemia (Fig. 6B).
The rate of ATP utilization in cytosol through ATP hydrolysis
slowly decreased (exponentially) by about 20% during 76%
ischemia and returned to its baseline level during the recovery
period (Fig. 9C, dashed line). However, the rate of ATP synthesis
in mitochondria through oxidative phosphorylation (O2 utiliza-
tion) rapidly decreased (as a step) by about 22% during 76%
ischemia (Fig. 9C, dotted line) due to a rapid reduction in O2
delivery to mitochondria by capillary blood flow (Fig. 8B), in spite
of sufficient increases in the mitochondrial redox potential
[NADH]/[NAD
+] (Fig. 5B) and phosphorylation potential
[ADP]/[ATP] (Fig. 5F) (the activators of the lumped oxidative
phosphorylation reaction). This transient deficit in ATP (Fig. 9D
solid line) was mostly matched by the ATP production from the
creatine kinase ATP buffer reaction (Fig. 9D, dashed-dotted line).
The ATP supply from glycolysis/glycogenolysis (ATP deficit –
ATP supply from creatine kinase reaction) during ischemia and
recovery was almost constant, indicating that glycolysis/glycogen-
olysis is not a major source of ATP supply during partial ischemia.
The time to reach new steady states (response time) for the ATP
hydrolysis and creatine kinase reactions were about 15 minutes,
while that for the ATP synthesis (or O2 consumption) reaction was
about 5 minutes. Thus, in contrast to our previous model [1], the
present compartmentalized model is able to correctly simulate the
dynamic responses of cytosolic and mitochondrial metabolic
reaction fluxes that are responsible in the production and
utilization of ACoA and ATP. Furthermore, the model is able to
link substrate metabolism (carbohydrates vs. fat) to energy
metabolism in skeletal muscle during physiological perturbations
such as muscle ischemia.
Discussion
Modeling framework for analysis of sparse in vivo
experimental data
Analysis of dynamic changes in cellular metabolism and
energetics in skeletal muscle in vivo in response to reduced blood
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Figure 8. Model-predicted dynamic responses of O2 and CO2 (total contents and partial pressures) in the capillary blood (or venous
blood) and tissue cells during the resting, ischemia and recovery periods with a blood flow reduction of about 76%. The responses
were computed using the estimated optimal parameter values with the ischemia protocol: if (t,0 min | t.30 min) Q=0.9 L/min, else
Q=Qisch=0.216 L/min. The total O2 and CO2 contents are based on various forms of O2 and CO2 transports in the capillary blood and tissue cells (see
Materials S1).
doi:10.1371/journal.pone.0003168.g008
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available in vivo experimental data. Relatively few in vivo
measurements can be obtained of metabolite concentrations and
metabolic fluxes in subcellular compartments, such as mitochon-
dria. As a complementary approach to experimental measure-
ments and as a framework for quantitatively analyzing available in
vivo data, a physiologically-based, whole-organ level model of
skeletal muscle cellular metabolism and energetics is developed.
This model emphasizes a multi-scale, top-down systems approach
[1–8] for quantitative understanding of metabolic processes at the
molecular, subcellular and cellular levels in relation to the tissue-
organ responses. For this purpose, integration of information was
required from cellular metabolic pathways and fluxes of substrate
and energy metabolism in cytosol and mitochondria, cellular
metabolic control mechanisms, catalytic enzyme kinetic mecha-
nisms, subcellular compartmentation and metabolites volumes of
distribution, inter-domain transport mechanisms, and tissue-
specific skeletal muscle metabolic characteristics. Since the extent
to which enzyme activities and kinetic (Michaelis-Menten)
constants determined from in vitro experimental studies are
applicable to in vivo conditions is uncertain, our multi-scale, top-
down modeling approach provides a unified, systematic frame-
work for modeling and analysis of in vivo complex metabolic
systems. A major improvement of the present model over our
previous model [1] is the incorporation of distinct intracellular
cytosolic and mitochondrial compartments. The present model
distinguishes the cytosolic and mitochondrial [ATP]/[ADP] and
[NADH]/[NAD
+] ratios (major modulators of several key
metabolic reactions in cytosol and mitochondria) and incorporates
metabolic reactions and transport processes of key chemical
species, including glucose, lactate, pyruvate, free fatty acid, oxygen
and carbon dioxide (Fig. 1).
The governing model equations are based on dynamic mass
balances of chemical species in spatially-lumped, capillary blood-
interstitial fluid domain and two distinct intracellular cytosolic and
mitochondrial domains (Fig. 2). These include the dynamic mass
balances of O2 and CO2 which are developed by accounting for
their distinct transport and binding mechanisms (hemoglobin and
myoglobin-mediated) in these three domains [25,26]. However,
since not much information is available regarding the blood flow
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Figure 9. Model-predicted dynamic responses of metabolic reaction fluxes linked to the production and utilization of ACoA (A,B)
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metabolic characteristics were not considered in the present study.
Instead, different fiber types were lumped together to an effective
active muscle volume with an effective blood flow supplying
oxygen and other nutrients to the lumped muscle volume, which is
sufficient to investigate the dynamic metabolic responses to muscle
ischemia (also see discussions in Section 4.4). Furthermore, since
the phenomenon of muscle acidification/alkalization (i.e., proton
handling) under physiological stresses, such as muscle ischemia, is
highly complex [17,21], this was not accounted for in the present
model.
In this model, the compartmentalized lumped biochemical
reactions along the cellular metabolic pathways are the stoichio-
metrically coupled sequential elementary reactions, which include
the compartmentalized metabolic energy controller pairs ATP-
ADP and NADH-NAD
+ whose ratios (phosphorylation and redox
potentials) modulate (or fine tune) the reaction fluxes in the
subcellular domains [2,23]. The lumped reactions for which the
resting Gibbs free energy (DG) is large and negative in favor of
product formation are considered irreversible [24]. The reversible
reactions like lactate dehydrogenase (LDH), creatine kinase (CK),
and adenylate kinase (AK) are decomposed into two separate
irreversible reactions with distinct kinetics. This can be justifiable
based on the fact that the in vivo metabolic systems are
nonequilibrium open systems and the biochemical reactions
usually operate far from true equilibrium under physiological
stimuli (also see discussions in Section 4.3). Besides, the
consideration of the law of microscopic reversibility (thermody-
namics) requires a detailed knowledge of proton handling in
cytosol and mitochondria [17,21], which is not considered in this
phenomenological modeling study. The metabolic reaction fluxes
in the subcellular cytosolic and mitochondrial domains are
expressed in terms of a general phenomenological Michaelis-
Menten equation with the coupled controller factors involving the
compartmentalized [ATP]/[ADP] and [NADH]/[NAD
+] energy
controller ratios. These flux expressions characterize the behavior
of saturable enzyme kinetics and in vivo control mechanisms
observed experimentally [23,31]. In comparison to the previous
models in the literature [3–5,11–21], the present model is a self-
consistent, physiologically-based, multi-scale computational model
dealing with cellular metabolism and energetics in skeletal muscle
in vivo at the whole-organ level.
Optimal parameter estimation for the large-scale
metabolic model
A major challenge of this work was to evaluate a large number
of unknown model parameters (precisely a total of 101) with
relatively sparse experimental data from in vivo studies on muscle
ischemia [22]. To deal with this under-determined, ill-conditioned
problem, we had to devise a special optimization strategy (see Ref.
[1] for details). Briefly, preliminary estimates of the model
parameters were obtained based on resting, steady-state flux
balance analysis together with the information on resting, steady-
state metabolites blood and tissue cells (cytosol and mitochondria)
concentrations, metabolites uptake-release (UR) rates or arterio-
venous (AV) differences, and metabolic reaction flux rates
gathered from various literature sources on skeletal muscle cellular
metabolism in normal human subjects (Tables 1 and 2). With these
preliminary parameter estimates, the model could not simulate the
dynamic cellular metabolic responses to muscle ischemia.
However, these estimates provided a good starting point in an
iterative process of optimization to obtain the optimal parameter
estimates (Tables 3 and 4) that yield the best least-squares fit of the
model to the data [22] (Figs. 3 and 4). A good starting point is
essential for optimization of large-scale problems with gradient-
types of optimization algorithms, such as the generalized reduced
gradient algorithm (GRG2) [34], used in the present study. The
first step of obtaining the preliminary parameter estimates
provided accurate optimal estimates of the 12 transport param-
eters (4 l,4Tmax and 4 Mm) and 10 partition coefficients (10 s),
resulting in a reduction of 22 kinetic parameters for estimation
from the dynamic experimental data from muscle ischemia.
The key to success of our parameter estimation approach for
obtaining the remaining 79 kinetic parameters (second step) was
the incorporation of constraint information to the maximum
extent in the GRG2 optimization algorithm [34]. These include (1)
the bound constraints on kinetic parameters from experimental
studies, (2) the nonlinear equality (physiological) constraints
relating fluxes and concentrations at resting, steady-state, and (3)
the nonlinear inequality (thermodynamic) constraints relating
fluxes and Gibbs free energy for reversible reactions: wnet.DG#0
[35–37]. Also, the bounded estimation of active muscle volume
(Vmus) and ischemic blood flow (Qisch) (not known from the
experimental protocol of Katz [22]) provided additional degrees of
freedom for fitting the model to the data. Use of such constraints
reduced the number of unknown model parameters for simulta-
neous estimation (e.g., the 26 Vmax parameters could be explicitly
estimated from the flux-concentration relationships at resting,
steady-state). Such constraints also reduced uncertainty and
enhanced accuracy in the estimated parameter values.
Since the available experimental data [22] were relatively sparse
in comparison to the number of unknown model parameters, the
parameter estimates for this under-determined, ill-conditioned
problem were expected to be non-unique. The efficiency and
robustness of this parameter estimation approach was tested
previously [1] in detailed with repeated parameter estimations
with various initial parameter estimates (guesses) and with
parameter sensitivity analysis. Various parameter estimates of
the more sensitivity model parameters spanned in a small
neighborhood of the accepted optimal parameter estimates. Re-
estimation of the model parameters for the present extended
compartmentalized model with the same parameter estimation
approach and the quality of the model fitting to the experimental
data (Figs 3 and 4) further testifies the robustness of the parameter
estimation approach.
Model predictions related to muscle ischemia
This physiologically-based, multi-scale computational model of
skeletal muscle cellular metabolism and energetics can simulate
dynamic metabolic changes in cellular and subcellular compart-
ments and provide quantitative analysis of the mechanisms of
metabolic regulation during physiological stresses (e.g., reduced
blood flow and oxygen supply to mitochondria associated with
muscle ischemia). Model simulations based on the estimated
optimal parameter values correspond well to the experimental
data on muscle ischemia of Katz [22] (Figs. 3 and 4). The optimal
estimates of active muscle volume Vmus<4 L and ischemic muscle
blood flow Qisch<0.216 L/min (Table 3) indicate that only ,16%
of whole muscle volume (,25 L) was actively participating in
cellular metabolism during reduced oxygen delivery to mitochon-
dria induced by a blood flow reduction of ,76% from the resting
level of 0.9 L/min. Though these estimates are slightly different
from those estimated previously [1] (Vmus<5 L and
Qisch<0.135 L/min), when scaled to one leg with a resting blood
flow of 0.45 L/min, the estimated Vmus value becomes ,2L
which lies well within the experimental range of 1.5–3 L for one
leg quadriceps femoris muscle [38–41]. The experimental data
[22] used in this computational study were also based on
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whole muscle is not uniformly perfused and that only a fraction of
the muscle mass, in accord with metabolic demand, participates in
cellular metabolic processes.
The model simulations of cellular [GLC], [G6P], [LAC],
[PYR], and [LAC]/[PYR] with ,76% ischemia corresponded
well with the experimental data (Fig. 3). To simulate [GLC] and
[G6P] dynamics, and to some extent [LAC] and [PYR] dynamics
in response to muscle ischemia, the model had to account for the
inhibition of hexokinase reaction by [G6P] and activation of
glycogen phosphorylase reaction by [AMP]/[ATP]. [G6P]
increased during ischemia due to the increased [AMP]/[ATP]
ratio and increased glycogenolysis flux. The increased [G6P]
decreases the flux of hexokinase and glucose utilization. As a
result, the glucose taken up by the muscle tissue cells is
accumulated during ischemia.
The model-simulated muscle [PCR], [CR], [PCR]/[CR], [PI],
[ATP], [ADP], [ATP]/[ADP], and [AMP] with ,76% ischemia
were in close agreement with the experimental data (Fig. 4). One
of the key aspects in achieving these successful model simulations
and good fittings was to model each of the reversible reactions like
creatine kinase (CK) and adenylate kinase (AK) as two separate
irreversible reactions with distinct kinetics. The forward and
reversible reaction fluxes were considered regulated by the
phosphorylation potentials [ATP]/[ADP] or [ADP]/[ATP] in
the cytosol (Materials S2). Without considering such control
mechanisms, it was not possible to simulate the experimental data
on these high-energy metabolites during muscle ischemia and
reperfusion.
We tested fitting the model to the data using alternative flux
expressions for the CK and AK (also LDH) reversible reactions
satisfying the Haldane relationship and thermodynamic equilibri-
um conditions. However, we were unable to achieve good fittings
for the high-energy metabolites. This may be due to the limitations
in the present model, or may be the fact that the data do not
support thermodynamic equilibrium of the CK reaction during
ischemia/recovery. It is evident from the data of Katz [22] that the
changes in muscle [PCR]/[CR] and [ATP]/[ADP] ratios during
ischemia are not proportional. The muscle [PCR]/[CR] ratio
decreased substantially from a resting level of ,2.0 to ,1.2
(,40%) during ischemia (Fig. 5D), while the muscle [ATP]/
[ADP] ratio decreased only little from a resting level of ,7.5 to
,7.0 (,7%). However, the dynamics of cytosolic [ATP]/[ADP]
ratio was not available from the experimental study, which
determines the thermodynamic equilibrium for the CK reaction.
With our assumption of a constant cytosolic to mitochondrial ratio
of [ATP] and [ADP] (and other common chemical species) during
ischemia/recovery, the model predicted a comparable 7%
decrease in cytosolic [ATP]/[ADP] ratio from a resting level of
,332 to ,310 during the ischemia period (Fig. 5E). As a
consequence, the CK mass action ratio ([CR][ATP])/
([PCR][ADP]) increased from a resting value of ,166 to ,260
during ischemia, instead of being a constant (,166) (the CK
apparent equilibrium constant at pH=7) [17].
This issue may be resolved by including the dynamics and
buffering of cytosolic and mitochondrial pH [17,21] and, to some
extent, by distinguishing the dynamics of common metabolites
within the subcellular cytosolic and mitochondrial compartments.
The later will necessitate incorporation of transport mechanisms of
common metabolites across the mitochondrial inner membrane,
e.g., proton pumps, ATP/ADP translocase, PI/H
+ cotransporter,
and exchange of TCA cycle substrates/intermediates [18,21].
Since ,98% of ADP is in mitochondria and only ,2% of ADP is
in cytosol at normal, resting steady-state conditions, a small
relative change in whole cell [ADP] may correspond to a huge
relative change in cytosolic [ADP], and hence a huge relative
change in cytosolic [ATP]/[ADP] ratio. This can lead to the
displacement of thermodynamic equilibrium of ATP/ADP
translocase without displacing the thermodynamic equilibrium of
CK reaction. Note that the cytosolic [ATP]/[ADP] ratio needs to
decrease proportionally to the cytosolic [PCR][H
+]/[CR] ratio for
maintaining the thermodynamic equilibrium of the CK reaction.
This information will be the mechanistic basis for the extension of
the current model which can be used to analyze the data on high-
energy phosphate metabolites.
With the estimated optimal parameter values, the present model
is able to correctly simulate the dynamic metabolic responses of
compartmentalized cytosolic and mitochondrial phosphorylation
and redox potentials (Fig. 5), key mitochondrial and TCA cycle
metabolite concentrations (Fig. 6), and other key metabolite
concentrations and metabolic fluxes (Figs. 7–9) in skeletal muscle
during ischemia and reperfusion for which no experimental data
are available. Some of these simulations may be questionable
without further validation, such as the predictions of cytosolic and
mitochondrial phosphorylation and redox potentials (Fig. 5).
However, these predictions are consistent with the dynamic
responses of cellular or cytosolic [PCR]/[CR] and [LAC]/[PYR]
ratios. Some of these simulations could not be obtained accurately
with our previous model [1].
Our compartmentalized model simulations show that the
metabolic changes were negligible with respect to the extent of
blood flow reduction up to ,70%, beyond which a profound
derangement in substrate and energy metabolism occurred due to
reduced supply of oxygen to mitochondria. The metabolic changes
during severe ischemia (,76% and beyond) include (1) a switch
from a net pyruvate uptake and utilization to a net pyruvate
production and release (Figs. 3C and 7B); (2) an increase in the
redox potential [NADH]/[NAD
+] (Figs. 3(E,F) and 5(A,B))
accompanied by a net formation and accumulation of cytosolic
LAC and PYR (Fig. 3(C,D)) and mitochondrial ACoA (Figs. 6B
and 9(A,B)); (3) an increase in the glycolytic and creatine kinase
contributions to ATP formation (Fig. 9(C,D)) accompanied by a
net depletion of cytosolic PCR (ATP stores) (Fig. 4A). In general,
these predictions are in agreement with experimental results from
studies under similar conditions [42–44]. However, since our
model does not differentiate between FADH2 and NADH, the less
efficient fuel (i.e., fats) –from the oxygen consumption point of
view– is considered to have the same oxygen cost as carbohydrates
for ATP production.
Limitations of the model
In this multi-scale, multi-compartmental, top-down integrated
model of cellular metabolism and energetics in skeletal muscle, the
substrate and cation transport mechanisms between cytosol and
mitochondria are not incorporated. Instead, these two domains
are assumed to be in fast equilibrium with each other with the
common metabolites having the similar dynamics (i.e., Cmit,j=sj.C-
cyt,j, with the partition coefficients sj constant). This is projected in
the model-simulated dynamic responses of cytosolic and mito-
chondrial phosphorylation and redox potentials (i.e., [ATP]/
[ADP] and [NADH]/[NAD
+] ratios) (Fig. 5). This assumption
may be reasonable as a first approximation, since not much
information is available regarding the dynamic responses of
common metabolites to physiological stimuli (e.g., muscle
ischemia) in these two subcellular domains (cytosol and mitochon-
dria). This assumption may also be reasonable as long as the
common metabolite concentrations do not vary appreciably within
these two subcellular domains during physiological stresses.
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and [NADH]/[NAD
+] ratios during ischemia/recovery, which
are major modulators of several key metabolic reactions in cytosol
and mitochondria. Therefore, the model may not accurately
predict the dynamics of metabolite concentrations and metabolic
fluxes that are critical in the regulation of fuel (carbohydrate, fat,
and lactate) metabolism and cellular respiration during physiolog-
ical perturbations, such as ischemia, hypoxia, and exercise.
Furthermore, the inclusion of FADH2 as a reducing equivalent
(produced through oxidation of fatty acids) is essential when
investigating the relative contribution of carbohydrate and fat
oxidations in the synthesis of ATP in mitochondria.
Another limitation in the present model is that the model does not
account for blood flow heterogeneity and fiber type distributions
associated with skeletal muscle cellular metabolism. Specifically, the
capillary blood domain is considered spatially-lumped and the
advective-diffusive transport of chemical species in capillary blood is
ignored. Such compartmental modeling may not account for
situations where important gradients of chemical species exist (e.g.,
due to distinct metabolic characteristics associated with different fiber
types). In skeletal muscle, where the blood flow is highly
heterogeneous due to complex capillarization and fiber type
distributions, more than 70% of arterial oxygen is extracted from
the blood before it leaves the microcirculation [45]. High extraction
resultsin large intracellularand intravasculargradients of oxygen and
other nutrients. Therefore, the well-mixed assumption may not be
valid and compartmental modeling may not account for the
heterogeneity of oxygen transport and consumption in different fiber
types. These issues can be addressed through spatially-distributed
modeling of oxygen transport and consumption, coupled with other
substrates and CO2 [19,26].
Finally, in the present model most of the lumped biochemical
reactions in the cellular metabolic pathways are considered
irreversible in the direction of product formation. Although the flux
in the reverse direction is almost one order of magnitude smaller than
the flux in the forward direction under normal, resting steady-state
conditions, their magnitudes may change during physiological
perturbations such as ischemia, hypoxia or exercise. Therefore, it
would be advantageous to consider allthe biochemical reactions to be
reversible and their fluxes to satisfy the thermodynamic equilibrium
constraints [37], including the dynamics and buffering of pH [17,21],
which can affect the apparent equilibrium constants and standard
Gibbs free energy of the reactions.
Future model developments and potential applications
Including the substrate and cation transport mechanisms between
cytosol and mitochondria and distinguishing common metabolites
dynamics within these subcellular domains would be important in the
analysis of dynamic cellular metabolic responses to high intensity
exercise. The subcellular compartmentalization could account for
distinct volumes of metabolites distribution, for example, metabolic
channeling for glycolysis [6–8]. This is a way to recognize that the key
glycolytic enzymes are bound together to form a multi-enzyme
complex near the sarcolemma and sarcoplasmic reticulum. To
investigate the effects of spatial locality due to blood flow heterogeneity
and fibertypedistributionsonmetabolicresponsestomuscleischemia,
hypoxia or exercise, one will require spatially-distributed models
involving parallally-arranged capillaries representing different muscle
fiber types. Furthermore, the use of alternative kinetic flux expressions
based on a Michaelis-Menten formalism for reversible enzymatic
reactions would satisfythe thermodynamic equilibrium conditions and
would provide additional thermodynamic constraints for kinetic
parameter estimation [37]. As in our previous paper [1], a formal
dynamic parameter sensitivity analysis can be carried out to
understand the relative importance of the model parameters on the
measured outputs. This information can be used to improve
confidence in the estimates of key model parameters by fixing the
values of the least sensitive parameters (parameter space reduction
approach).
With these enhancements and with additional metabolic
pathways similar to those of the models of cellular metabolism
and energetics in cardiac muscle [6–8], such as the inclusion of
FADH2 as a reducing equivalent, the advanced model of cellular
metabolism and energetics in skeletal muscle can be used to
analyze physiological responses to exercise (increased energy
demand). Specifically, the model can assist in providing insight
into long-standing or paradoxical questions, such as the extent of
control that mitochondrial oxygen concentration and redox state
exert over the rate of lactate production in the cytosol during
heavy intensity exercise. In general, a multi-scale computational
model of cellular metabolism and energetics in tissue/organ
systems within the body that incorporate sufficient mechanistic
processes can be used to (1) analyze and interpret in vivo
experimental data; (2) provide new hypotheses as well as suggest
how to test a given hypothesis; (3) design critical experiments; (4)
quantify and predict dynamic responses to physiological stimuli
that can not be directly measured; (5) evaluate relative importance
of metabolic pathways and fluxes and their regulatory mechanisms
under both normal and pathological conditions; and (6) provide
the mechanistic basis for simulating integrated effects of altering
enzyme activities and substrate concentrations through pharma-
cological agents and/or dietary inputs.
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